INTRODUCTION
The etiology of acute respiratory distress syndrome (ARDS) is associated with damage to the membrane of capillaries of the alveoli which compromises their permeability and results in edema [1] . Aspiration pneumonitis is one of the important causes of ARDS [2] . Studies so far are yet to unravel the signal pathways implicated in the pathogenesis of ARDS. Nonetheless, research findings indicate that ARDS may be triggered on and amplified by cytokine mediation through enhanced expression of high mobility group box 1 (HMGB1), interleukin (IL)-1, IL-6,
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and tumor necrosis factor (TNF)-α in the lungs [3] .
In situations such as autoimmune diseases and sepsis, the anti-inflammatory functions of the cholinergic nervous system results in blockage of uncontrolled expression of pro-inflammatory mediators, through the vagus nerve [4, 5] . Vagal efferent stimulation can protect against Mesobuthus tamulus venom-induced ARDS through anti-inflammatory mechanism [6] . The regulatory influence of the efferent vagus nerve on expression of pro-inflammatory cytokines is mediated through the cholinergic antiinflammatory route which involves α7nAChR-dependent signal cascade [7] . This antiinflammatory route is under the control of neuronal muscarinic mechanisms [8] . It has been demonstrated that galantamine (GAL), a negative effector of cholinesterase, mitigated lipopolysaccharide-induced inflammatory responses in animal models through the cholinergic route [9] .
The present study investigated the protective effects of GAL against acid aspiration-induced ARDS, and the mechanism involved.
EXPERIMENTAL Animals
Adult New Zealand white rabbits (male, weight range: 1.9 -2.5 kg) were subjected to pentobarbital anesthesia (3 %, 25 mg/kg body weight), followed by uninterrupted administration at the rates range of 5 -10 mg/kg body weight/h. The rabbit muscles were relaxed by administration of 0.2 mg/kg body weight pipecuronium bromide. The rabbits were ventilated during tracheotomy in SIMV mode with the aid of a Drager Evita 2 Dura ventilator (Drager Medical AG & Co., Germany), under the following settings: 6 ml/kg body weight VT; maintenance of PaCO 2 within 35 -45 mmHg via RR adjustments; FIO 2 = 0.3; inspiratory-toexpiratory ratio of 1:1, and 2 cmH 2 O positive end-pressure.
Physiological saline infusion was maintained at a constant rate of 8 ml/kg body weight/h, to ensure that arterial pressure values were ˃ 80 mmHg. No vasoactive drugs were applied during the study which was approved by the Animal Ethical Committee of The People's Hospital of Chongqing City (approval no. 2017040502), and implemented according to "Principles of Laboratory Animal Care" (NIH publication no. 85 -23, revised 1985) [10] .
Reagents
The reagents used and their sources were: GAL (EMD Biosciences Inc.,USA); α7 nicotinic receptor blocking agent i.e. methyllycaconitine (MLA) as well as corticosterone and cytokine assay kits (R & D Systems, USA); atropine sulfate (ATS, Hefeng Pharmaceutical Co., China); rabbit anti-HMGB1 polyclonal antibody (Boster Biotechnology Company, China), and HMGBI kits (Boster Biotech. Company Ltd, USA). Western blotting antibodies were product of Pierce Biotechnology, USA).
Vagotomy
In each rabbit, the right cervical vagus nerve was exposed, ligated using a 4 -0 silk suture, and parted.
Preparation of ARDS model
Intra-tracheal instillation of 10 -1 M HCL was done in the two lateral positions (1.5 ml/kg per side) prior to a pause for about 5 sec at a peak pressure of 25 cmH 2 O. The ARDS model was considered stable 30 min later if PaO 2 /FIO 2 was less than 200, otherwise, the procedure was repeated until PaO 2 /FIO 2 reached the predefined standard level.
Experimental protocols
Rabbits were observed for 30 min for stabilization after cannulation, and were then randomized into six groups (26 rabbits/group). Group 1: ARDS group; group 2 (ARDS + GAL group), in which GAL (4 mg/kg) was given i.p. 30 min prior to hydrochloric acid aspiration; group 3 (ARDS + GAL + MLA), in which MLA (4 mg/kg, i.p.) was administered 15 min before GAL; group 4 (ARDS + GAL + Vag) in which vagotomy was done 15 min before intraperitoneal GAL; group 5 (ARDS + GAL + ATS), in which ATS (4 mg/kg, i.p.) was administered 15 min before intraperitoneal GAL; group 6 (control), given in place of treatment, equivalent volume of saline intra-tracheally.
Survival study
The population of rabbits that survived in the six groups were noted 72 h after the hydrochloric acid aspiration.
Histological analysis
Four (4) h after hydrochloric acid aspiration, the rabbits were euthanized (n = 10). Lung tissue samples were processed for light microscopy in accordance with standard procedures [11] . Histological changes were scored by a pathologist naïve to the animal treatments, on a 5-point scale based on presence of, and extent of lesions such as edema, hemorrhage, and neutrophils: absent = 0, mild = 1, moderate =2, severe = 3, and 4 = overwhelming, with a maximum score of 12 points [12] .
Wet-to-dry weight ratio
Following a 4-h euthanization, the right lungs were ligated, excised and washed with phosphate buffered saline (PBS). They were then blotted and weighed (wet weights). Thereafter, the samples were oven-dried to constant weights for 48 h at a temperature of 80 °C (dry weights). These measurements allowed for determination of the ratio of wet-to-dry (W/D).
Corticosterone assay
Blood was taken from the euthanized rabbits through cardiac puncture at 4 and 12 h, and used for assay of corticosterone levels in serum in line with instructions contained in corticosterone assay kits.
Cytokine assay
Lung tissue homogenate was prepared at pH 7.2 in PBS treated with protease inhibitor, using lung samples obtained 4 h after hydrochloric acid aspiration, rinsed of blood, and homogenized using Polytron (Brinkman) in homogenization buffer (PBS, containing a protease inhibitor cocktail, pH 7.2) (n = 10). The homogenates were clarified by centrifugation, and the resultant supernatants were subjected to ELISA assays for TNF-α, IL-1β and IL-6. The protein contents of the supernatants were estimated using the Bradford procedure.
Western blot analysis for HMGB1
Lung tissue protein extracts prepared from samples taken after 12 h of HCL exposure were subjected to Western blot analysis in line with standard procedures. Following sequential incubation of the membrane with the respective primary and secondary antibodies, the membranes were washed thrice in TTBS buffer and visualized through chemiluminescence.
Statistical analysis
All data are presented mean ± standard deviation (SD. Comparisons between different groups were done with analysis of variance (ANOVA) and Student-Newman-Keuls q-test. Values of p < 0.05 were taken as indicative of statistically significant differences.
RESULTS

Mortality
There was no mortality in the control group. However, mortalities in ARDS, ARDS + GAL, MLA, and ATS groups were 87.5, 12.5, 50 and 50 %, respectively.
Pathological changes in lung tissue
No lesions were evident in the photomicrograph of lung tissue from the control group. On the other hand, HCL aspiration for 4 h was associated with clear evidence of histopathological changes such as inflammation, hemorrhage, thickened alveolar walls, and pulmonary edema. However, GAL pretreatment led to significant reductions in the HCL-induced pulmonary lesions. Methyllycaconitine, vagotomy and atropine sulfate reduced GAL-induced reduction in lung lesions and inflammation. These results are shown in Figures 1A -1F . The degree of pulmonary damage was significantly higher in ARDS rabbits than in the GAL group (p ˂ 0.05). Rabbits in the MLA, Vag and ATS groups had significantly higher aggregate scores in lung lesions, when compared with corresponding scores for GAL group (p < 0.05, Figure 1G ). 
Influence of GAL on W/D index
The W/D ratio of the control group was significantly lower than that of the ARDS (p < 0.05). However, the GAL treatment led to significant decrease in W/D relative to the ARDS group (p < 0.05).The W/D ratios in the MLA, Vag and ATS groups were significantly higher than that of the GAL group, indicating that methyllycaconitine, vagotomy and atropine sulfate reduced GAL-induced attenuation of the degree of pulmonary edema in ARDS (p < 0.05, Figure 2 ). 
GAL suppressed HMGB1 expression in lungs
HMGBI was expressed at a significantly higher level in the ARDS group than in control, but HMGBI expression was significantly reduced in the GAL group relative to the ARDS group (p < 0.05). In addition, HMGB1 protein expression in MLA, Vag and ATS groups were higher, when compared with corresponding expressions in the control, indicating that methyllycaconitine, vagotomy and atropine sulfate reduced GAL-induced downregulation of HMGB1 expression (p < 0.05, Figure 3 ). 
Pro-inflammatory cytokine expressions in lungs
In the ARDS group, TNF-α, IL-1β and IL-6 protein expressions at 4 h were significantly higher, relative to the control and GAL groups (p < 0.05)). This suggests that GAL suppressed the expressions of TNF-α, IL-1β and IL-6 in the lungs. In addition, TNF-α, IL-1β and IL-6 protein expressions were significantly higher in the MLA, Vag and ATS groups than in the GAL group, suggesting that methyllycaconitine, vagotomy and atropine sulfate reduced GAL-induced downregulation of these cytokines (p < 0.05, Figure 4 ). 
Corticosterone levels
There were no significant alterations in serum corticosterone levels amongst the various groups.
DISCUSSION
Acute acid aspiration-induced injury is a biphasic injury pattern at 1 h and 4 h. The first phase results from a direct physiochemical process, while the second phase is mediated by neutrophils, and is consistent with an acute inflammatory response [13] . Elevations in TNF-α, IL-1, and IL-6 are implicated in the etiology of ARDS. Neuronal cholinergic function is enhanced by GAL through inhibition of acetylcholinesterase (AChE), an action aided by its ability to traverse the blood brain barrier (BBB) [14] . In the present study, it was shown that GAL suppressed acute inflammatory response during the second phase of acute of acid aspirationinduced ARDS, and also suppressed the inflammation mediator HMGB1, but had no appreciable effect on serum concentrations of corticosterone. Notwithstanding the differences in animal models used, these results are in agreement with the report that GAL protects rats from LPS-provoked ALI [15] .
The control of the neuronal cholinergic route of anti-inflammation in the efferent vagus nerve is poorly understood. However, it is known that this process is regulated in a central fashion. In the present study, it was demonstrated that GALassociated mitigation of inflammation was diminished through vagus nerve transection. Signal transmission from the vagus nerve is regulated by the activities of muscarinic receptors, as well as AChE [8] . The findings of present study have shown that atropine sulfate, an antagonist of muscarinic receptors which can also pass through BBB, eliminated GALmediated mitigation of inflammation. It has been demonstrated that impulses from the vagus nerve regulate the inflammatory processes centrally and peripherally through the nicotinic ACh receptor [16] . In this study, it was shown that the α7nicotinic receptor blocking agent methyl lycaconitine reduced GAL-induced suppression of acute inflammatory response.
CONCLUSION
The results of this study demonstrate that GAL mitigates acid aspiration-induced ARDS via inhibition of pro-inflammatory cytokine availability whose mechanism involves an interplay between α-7nAChR, vagus nerve and muscarinic receptors. Thus, GAL has promising a potential for clinical application in suppressing inflammatory responses associated with ARDS.
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